AU
UK
CA
NZ
IND
US
Key HighlightsIVF surged 10.59% on 29 May 2026 on extreme 245.72x relativeVolume, one of the most abnormal tape readings on the entire small-cap market, signalling aggressive positioning in post-reverse-split nano-cap.Recent Family Beginnings fertility clinicAcquisition(February 2026) and 1-for-5 reverse split (March 2026) provide operational backdrop …
Absci Corporation (Nasdaq:ABSI) share price climbed 11.02% on 29 May 2026, closing at $6.75 as investors rotated into artificial intelligence-linkedGrowth Stocksduring a record-setting session for US equities. While no major company-specific announcement emerged as the primary catalyst, the stock appeared to benefit from renewed …
Key HighlightsFDMT rose 10.48% on 29 May 2026 to $9.91 on relativeVolumeof 5.96x, driven by gene-therapy sector momentum following Replimune's FDA alignment on resubmission.Trading volume reached 3.32M shares as broader biotech sentiment improved on FDA priority-review signal for oncology gene therapy applications.The move occurred …
Advanced Biomed Inc. (Nasdaq:ADVB) share price surged 28.13% on 29 May 2026, closing at $5.01 and ranking among the top-performing US stocks of the session. The sharp move occurred despite the absence of a widely reported corporate announcement,Earningsupdate, or regulatory filing directly linked to …
Beat Broadens Across All Three Metrics
A Disputed Drug Finds a New Window
Shares of Aspire Biopharma Holdings climbed sharply in the latest U.S.Trading sessionas investors assessed a series of financing andCapital-structure announcements tied to the healthcare company’s ongoing strategic plans.
Absci Corporation (Nasdaq: ABSI), an AI-native drug-discovery company leveraging generative design to create antibody therapeutics, delivered meaningful clinical progress in Q1 2026, advancing its lead program ABS-201 beyond safety-cohort dosing into patient populations while simultaneously announcingWall Streetconference participation that will position the company for …
MarginExpansion and Instrument-Replacement Cycle Drive Agilent's Strategic Re-Rating
Key Highlights
Please wait processing your request...